Advances in understanding etiology of achondroplasia and review of management

Current Opinion in Pediatrics

Volumn 19, Issue 1, 2007, Pages 32-37

  Carter, Erin M ^a   Davis, Jessica G ^a   Raggio, Cathleen L ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Achondroplasia; Dwarf; Fibroblast growth factor receptor 3; Skeletal dysplasia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; GROWTH HORMONE;

ACHONDROPLASIA; BONE DYSPLASIA; CLINICAL EXAMINATION; CLINICAL FEATURE; DWARFISM; EAR INFECTION; EVALUATION; GENETIC ANALYSIS; HISTORY; INHERITANCE; KYPHOSIS; LORDOSIS; MACROCEPHALY; MANAGEMENT; MEDICAL LITERATURE; MIDFACE HYPOPLASIA; MOLECULAR GENETICS; MUSCLE HYPOTONIA; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SHORT LIMBED DWARFISM;

ACHONDROPLASIA; GROWTH PLATE; HUMANS; INFANT; MUTATION; PRACTICE GUIDELINES; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 33846335205     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328013e3d9     Document Type: Review

References (54)

1. Parrot J. Sur la malformation achondroplastique et le Diu Ptauh. Bull Soc Anthrop 1878; 1 (296).
2. Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet 1986; 23:328-332.
3. Le Merrer M, Rousseau F, Legeai-Mallet L, et al. A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nat Genet 1994; 6:318-321.
4. Velinov M, Slaugenhaupt SA, Stiolov I, et al. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nat Genet 1994; 6:314-317.
5. Francomano CA, Ortiz de Luna RI, Hefferon TW, et al. Localization of the achondroplasia gene to the distal 2.5Mb of human chromosome 4p. Hum Mol Genet 1994; 3:787-792.
6. Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994; 78:335-342.
7. Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994; 371:252-254.
8. Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995; 56:368-373.
9. Superti-Furga A, Eich G, Bucher HU, et al. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr 1995; 154:215-219.
10. Meyers GA, Orlow SJ, Munro IR, et al. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995; 11:462-464.
11. Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000; 21:23-39.
12. Ornitz DM, Xu J, Colvin JS, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996; 271:15292-15297.
13. Keegan K, Johnson DE, Williams LT, Hayman MJ. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A 1991; 88:1095-1099.
14. Peters K, Werner S, Chen G, Williams LT. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 1992; 114:233-243.
15. Deng C, Wynshaw-Boris A, Zhou F, et al. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996; 84:911-921.
16. Li Y, Mangasarian K, Mansukhani A, Basilico C. Activation of FGF receptors by mutations in the transmembrane domain. Oncogene 1997; 14:1397-1406.
17. Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 1996; 15:520-527.
18. Cho JY, Guo C, Torello M, et al. Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc Natl Acad Sci U S A 2004; 101:609-614.
19. Wyrobek AJ, Eskenazi B, Young S, et al. Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci U S A 2006; 103:9601-9606.
20. Wilkin DJ, Szabo JK, Cameron R, et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 1998; 63:711-716.
21. Risch N, Reich EW, Wishnick MM, McCarthy JG. Spontaneous mutation and paternal age in humans. Am J Hum Genet 1987; 41:218-248.
22. Mettler G, Fraser FC. Recurrence risk for sibs of children with 'sporadic' achondroplasia. Am J Med Genet 2000; 90:250-251.
23. Modaff P, Horton VK, Pauli RM. Errors in the prenatal diagnosis of children with achondroplasia. Prenat Diagn 1996; 16:525-530.
24. Hunter AG, Hecht JT, Scott CI. Standard weight for height curves in achondroplasia. Am J Med Genet 1996; 62:255-261.
25. Horton WA, Rotter JI, Rimoin DL, et al. Standard growth curves for achondroplasia. J Pediatr 1978; 93:435-438.
26. Spranger JW, Brill PW, Poznanski AK. Achondroplasia. In: Bone dysplasias: an atlas of genetic disorders of skeletal development. 2nd ed. New York: Oxford University Press; © 2002. pp 82-89.
27. Lachman RS. Neurologic abnormalities in the skeletal dysplasias: a clinical and radiological perspective. Am J Med Genet 1997; 69:33-43.
28. Onodera K, Niikuni N, Chigono T, et al. Sleep disordered breathing in children with achondroplasia. Part 2. Relationship with craniofacial and airway morphology. Int J Pediatr Otorhinolaryngol 2006; 70:453-461.
29. Pauli RM, Horton VK, Glinski LP, Reiser CA. Prospective assessment of risks for cervicomedullary-junction compression in infants with achondroplasia. Am J Hum Genet 1995; 56:732-744.
30. Reynolds KK, Modaff P, Pauli RM. Absence of correlation between infantile hypotonia and foramen magnum size in achondroplasia. Am J Med Genet 2001; 101:40-45.
31. Ain MC, Shirley ED, Pirouzmanesh A, et al. Genu varum in achondroplasia. J Pediatr Orthopaed 2006; 26:375-379.
32. Beals RK, Stanley G. Surgical correction of bowlegs in achondroplasia. J Pediatr Orthopaed B 2005; 14:245-249.
33. Aldegheri R, Dall'Oca C. Limb lengthening in short stature patients. J Pediatr Orthopaed B 2001; 10:238-247.
34. Pauli RM, Breed A, Horton VK, et al. Prevention of fixed, angular kyphosis in achondroplasia. J Pediatr Orthopaed 1997; 17:726-733.
35. Misra SN, Morgan HW. Thoracolumbar spinal deformity in achondroplasia. Neurosurg Focus 2003; 14:e1-e4.
36. Liao JC, Chen WJ, Lai PL, Chen LH. Surgical treatment of achondroplasia with thoracolumbar kyphosis and spinal stenosis: a case report. Acta Orthopaed 2006; 77:541-544.
37. Ain MC, Shirley ED. Spinal fusion for kyphosis in achondroplasia. J Pediatr Orthopaed 2004; 24:541-545.
38. Ain MC, Browne JA. Spinal arthrodesis with instrumentation for thoracolumbar kyphosis in pediatric achondroplasia. Spine 2004; 29:2075-2080.
39. Nicoletti B, Kopits SE, Ascani E, Mc Kusick VA. Human achondroplasia: a multidisciplinary approach. New York: Plenum Press; 1988.
40. Horton WA, Hecht JT. The chondrodysplasias. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects. New York: Wiley-Liss. © 1993; pp. 641-675.
41. American Academy of Pediatrics Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics 1995; 95:443-451.
42. Trotter TL, Hall JG, American Academy of Pediatrics Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics 2005; 116:771-783. An essential paper reviewing features and anticipatory management of achondroplasia broken down by age group. Includes growth charts appropriate for use in evaluating children with achondroplasia (from [23,24]). Available online at the American Academy of Pediatrics webpage: aappolicy.aappublications. org/cgi/reprint/pediatrics;116/3/771.pdf.
43. Aviezer D, Golembo M, Yayon A. Fibroblast growth factor receptor-3 as a therapeutic target for achondroplasia: genetic short limbed dwarfism. Curr Drug Targets 2003; 4:353-365.
44. Yasoda A, Komatsu Y, Chusho H, et al. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 2004; 10:80-86.
45. Horton WA. Recent milestones in achondroplasia research. Am J Med Genet 2006; 140A:166-169. Reviews ongoing basic scientific research working towards better understanding the biochemical mechanism underlying the features of achondroplasia. Presents current research investigating possible molecular therapeutic targets in achondroplasia.
46. Yamate T, Kanzaki S, Tanaka H, et al. Growth hormone (GH) treatment in achondroplasia. J Pediatr Endocrinol 1993; 6:45-52.
47. Seino Y, Yamanaka Y, Shinohara M, et al. Growth hormone therapy in achondroplasia. Horm Res 2000; 53 (Suppl 3):53-56.
48. Weber G, Prinster C, Meneghel M, et al. Human growth hormone treatment in prepubertal children with achondroplasia. Am J Med Genet 1996; 61:396-400.
49. Shohat M, Tick D, Barakat S, et al. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia. J Clin Endocrinol Metab 1996; 81:4033-4037.
50. Key LL, Gross AJ. Response to growth hormone in children with chondrodysplasia. J Pediatr 1996; 128 (5 Pt 2):S14-S17.
51. Stamoyannou L, Karachaliou F, Neou P, et al. Growth and growth hormone therapy in children with achondroplasia: a two-year experience. Am J Med Genet 1997; 72:71-76.
52. Tanaka N, Katsumata N, Jorikawa R, Tanaka T. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia. Endocr J 2003; 50:69-75.
53. Hertel NT, Eklöf O, Ivarsson S, et al. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial. Acta Pædiatr 2005; 94:1402-1410.
54. Ramaswami U, Rumsby G, Spoudeas HA, et al. Treatment of achondroplasia with growth hormone: six years of experience. Pediatr Res 1999; 46:435-439.